Clinical Trial Update: Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing low-dose prasugrel versus clopidogrel in patients undergoing stenting or flow diversion for unruptured intracranial aneurysms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Yonsei University | Conditions: Intracranial Aneurysm | Phase 4 | Status: UNKNOWN